172 related articles for article (PubMed ID: 28924001)
41. Mutations of the SDHB and SDHD genes.
Pawlu C; Bausch B; Neumann HP
Fam Cancer; 2005; 4(1):49-54. PubMed ID: 15883710
[TBL] [Abstract][Full Text] [Related]
42. Hereditary pheochromocytoma and paraganglioma.
Mazzaglia PJ
J Surg Oncol; 2012 Oct; 106(5):580-5. PubMed ID: 22648936
[TBL] [Abstract][Full Text] [Related]
43. Succinate dehydrogenase-deficient tumors: diagnostic advances and clinical implications.
Barletta JA; Hornick JL
Adv Anat Pathol; 2012 Jul; 19(4):193-203. PubMed ID: 22692282
[TBL] [Abstract][Full Text] [Related]
44. Genetic testing in pheochromocytoma or functional paraganglioma.
Amar L; Bertherat J; Baudin E; Ajzenberg C; Bressac-de Paillerets B; Chabre O; Chamontin B; Delemer B; Giraud S; Murat A; Niccoli-Sire P; Richard S; Rohmer V; Sadoul JL; Strompf L; Schlumberger M; Bertagna X; Plouin PF; Jeunemaitre X; Gimenez-Roqueplo AP
J Clin Oncol; 2005 Dec; 23(34):8812-8. PubMed ID: 16314641
[TBL] [Abstract][Full Text] [Related]
45. Review: Should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes?
Jiménez C; Cote G; Arnold A; Gagel RF
J Clin Endocrinol Metab; 2006 Aug; 91(8):2851-8. PubMed ID: 16735498
[TBL] [Abstract][Full Text] [Related]
46. Potential Pitfalls of SDH Immunohistochemical Detection in Paragangliomas and Phaeochromocytomas Harbouring Germline
Santi R; Rapizzi E; Canu L; Ercolino T; Baroni G; Fucci R; Costa G; Mannelli M; Nesi G
Anticancer Res; 2017 Feb; 37(2):805-812. PubMed ID: 28179334
[TBL] [Abstract][Full Text] [Related]
47. Low penetrance of paraganglioma and pheochromocytoma in an extended kindred with a germline SDHB exon 3 deletion.
Rijken JA; Niemeijer ND; Corssmit EP; Jonker MA; Leemans CR; Menko FH; Hensen EF
Clin Genet; 2016 Jan; 89(1):128-32. PubMed ID: 25827221
[TBL] [Abstract][Full Text] [Related]
48. Clinical Practice Guidance: Surveillance for phaeochromocytoma and paraganglioma in paediatric succinate dehydrogenase gene mutation carriers.
Wong MY; Andrews KA; Challis BG; Park SM; Acerini CL; Maher ER; Casey RT
Clin Endocrinol (Oxf); 2019 Apr; 90(4):499-505. PubMed ID: 30589099
[TBL] [Abstract][Full Text] [Related]
49. Germline SDHB mutations are common in patients with apparently sporadic sympathetic paragangliomas.
Klein RD; Jin L; Rumilla K; Young WF; Lloyd RV
Diagn Mol Pathol; 2008 Jun; 17(2):94-100. PubMed ID: 18382370
[TBL] [Abstract][Full Text] [Related]
50. 3P association (3PAs): Pituitary adenoma and pheochromocytoma/paraganglioma. A heterogeneous clinical syndrome associated with different gene mutations.
Guerrero-Pérez F; Fajardo C; Torres Vela E; Giménez-Palop O; Lisbona Gil A; Martín T; González N; Díez JJ; Iglesias P; Robledo M; Villabona C
Eur J Intern Med; 2019 Nov; 69():14-19. PubMed ID: 31431315
[TBL] [Abstract][Full Text] [Related]
51. SDHB immunohistochemistry for prognosis of pheochromocytoma and paraganglioma: A retrospective and prospective analysis.
Su T; Yang Y; Jiang L; Xie J; Zhong X; Wu L; Jiang Y; Zhang C; Zhou W; Ye L; Ning G; Wang W
Front Endocrinol (Lausanne); 2023; 14():1121397. PubMed ID: 37008946
[TBL] [Abstract][Full Text] [Related]
52. Succinate Mediates Tumorigenic Effects
Matlac DM; Hadrava Vanova K; Bechmann N; Richter S; Folberth J; Ghayee HK; Ge GB; Abunimer L; Wesley R; Aherrahrou R; Dona M; Martínez-Montes ÁM; Calsina B; Merino MJ; Schwaninger M; Deen PMT; Zhuang Z; Neuzil J; Pacak K; Lehnert H; Fliedner SMJ
Front Endocrinol (Lausanne); 2021; 12():589451. PubMed ID: 33776908
[TBL] [Abstract][Full Text] [Related]
53.
De Filpo G; Cilotti A; Rolli L; Pastorino U; Sonzogni A; Pradella S; Cantini G; Ercolino T; Nesi G; Mannelli M; Maggi M; Canu L
Medicina (Kaunas); 2020 Oct; 56(11):. PubMed ID: 33113876
[No Abstract] [Full Text] [Related]
54. SDHx-related pheochromocytoma/paraganglioma - genetic, clinical, and treatment outcomes in a series of 30 patients from a single center.
Donato S; Simões H; Pinto AT; M Cavaco B; Leite V
Endocrine; 2019 Aug; 65(2):408-415. PubMed ID: 31104306
[TBL] [Abstract][Full Text] [Related]
55. The penetrance of paraganglioma and pheochromocytoma in SDHB germline mutation carriers.
Rijken JA; Niemeijer ND; Jonker MA; Eijkelenkamp K; Jansen JC; van Berkel A; Timmers HJLM; Kunst HPM; Bisschop PHLT; Kerstens MN; Dreijerink KMA; van Dooren MF; van der Horst-Schrivers ANA; Hes FJ; Leemans CR; Corssmit EPM; Hensen EF
Clin Genet; 2018 Jan; 93(1):60-66. PubMed ID: 28503760
[TBL] [Abstract][Full Text] [Related]
56. SDHx mutation and pituitary adenoma: can in vivo 1H-MR spectroscopy unravel the link?
Branzoli F; Salgues B; Marjańska M; Laloi-Michelin M; Herman P; Le Collen L; Delemer B; Riancho J; Kuhn E; Jublanc C; Burnichon N; Amar L; Favier J; Gimenez-Roqueplo AP; Buffet A; Lussey-Lepoutre C
Endocr Relat Cancer; 2023 Feb; 30(2):. PubMed ID: 36449569
[TBL] [Abstract][Full Text] [Related]
57. Genetic mutation screening in an italian cohort of nonsyndromic pheochromocytoma/paraganglioma patients.
Castellano M; Mori L; Giacchè M; Agliozzo E; Tosini R; Panarotto A; Cappelli C; Mulatero P; Cumetti D; Veglio F; Agabiti-Rosei E
Ann N Y Acad Sci; 2006 Aug; 1073():156-65. PubMed ID: 17102082
[TBL] [Abstract][Full Text] [Related]
58. Hereditary paraganglioma/pheochromocytoma and inherited succinate dehydrogenase deficiency.
Favier J; Brière JJ; Strompf L; Amar L; Filali M; Jeunemaitre X; Rustin P; Gimenez-Roqueplo AP;
Horm Res; 2005; 63(4):171-9. PubMed ID: 15795514
[TBL] [Abstract][Full Text] [Related]
59. Paraganglioma and other tumour detection rates in individuals with SDHx pathogenic variants by age of diagnosis and after the age of 50.
Greenberg SE; Holman R; Kohlmann W; Buchmann L; Naumer A
Clin Endocrinol (Oxf); 2021 Sep; 95(3):447-452. PubMed ID: 34255389
[TBL] [Abstract][Full Text] [Related]
60. Rapid-sequence MRI for long-term surveillance for paraganglioma and phaeochromocytoma in patients with succinate dehydrogenase mutations.
Daniel E; Jones R; Bull M; Newell-Price J
Eur J Endocrinol; 2016 Dec; 175(6):561-570. PubMed ID: 27634942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
